NRX Pharmaceuticals, Inc. (NRXP) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nrx Pharmaceuticals, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.979 -- 00:00:06.263 Good afternoon, ladies and gentlemen, and welcome to the NRX Pharmaceuticals second 00:00:06.263 -- 00:00:11.406 quarter 2026 results conference call. At this time, all lines are 00:00:11.406 -- 00:00:16.690 in a listen-only mode. Following the presentation, we will conduct a question and answer 00:00:16.690 -- 00:00:21.814 session. Should we require any operator assistance, you may press star zero. 00:00:21.814 -- 00:00:26.157 I would now like to turn the conference call over to Sebastian Gomez of Astor Partners. 00:00:26.157 -- 00:00:28.577 Please go ahead. 00:00:28.679 -- 00:00:31.557 Thank you, operator, and welcome, everyone. 00:00:31.557 -- 00:00:35.319 Before we proceed with the call, I would like to remind everyone that certain statements 00:00:35.319 -- 00:00:38.600 made during this call are forward-looking statements under U.S. 00:00:38.600 -- 00:00:43.202 federal securities law. These statements are subject to risks and uncertainties that 00:00:43.202 -- 00:00:47.705 could cause actual results to differ materially from historical experience or present 00:00:47.705 -- 00:00:49.205 expectations. 00:00:49.205 -- 00:00:53.027 Additional information concerning factors that could cause actual results to differ from 00:00:53.027 -- 00:00:58.256 statements made on this call is contained in our periodic reports filed with the SEC. 00:00:58.256 -- 00:01:02.458 The forward-looking statements made during this call speak only as of the day hereof, 00:01:02.458 -- 00:01:07.601 and the company undertakes no obligation to update or revise the forward-looking statements. 00:01:07.601 -- 00:01:11.383 Information presented on this call is contained in the press release issued today and 00:01:11.383 -- 00:01:16.125 in the company's form 10-...